Growth Metrics

Braskem (BAK) EBIAT (2016 - 2025)

Braskem has reported EBIAT over the past 16 years, most recently at -$237.2 million for Q1 2025.

  • For Q1 2025, EBIAT changed N/A year-over-year to -$237.2 million; the TTM value through Mar 2025 reached -$1.9 billion, changed N/A, while the annual FY2025 figure was -$2.0 billion, 1.96% up from the prior year.
  • EBIAT for Q1 2025 was -$237.2 million at Braskem, up from -$987.8 million in the prior quarter.
  • Over five years, EBIAT peaked at $84.0 million in Q4 2021 and troughed at -$987.8 million in Q4 2023.
  • A 4-year average of -$348.8 million and a median of -$254.3 million in 2022 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: crashed 48.31% in 2021 and later plummeted 532.93% in 2023.
  • Year by year, EBIAT stood at $84.0 million in 2021, then crashed by 285.76% to -$156.1 million in 2022, then plummeted by 532.93% to -$987.8 million in 2023, then skyrocketed by 75.98% to -$237.2 million in 2025.
  • Business Quant data shows EBIAT for BAK at -$237.2 million in Q1 2025, -$987.8 million in Q4 2023, and -$524.2 million in Q3 2023.